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ABSTRACT
Objectives: The primary purpose was to compare the
odds of acute coronary syndrome-pertinent diagnostic
testing between self-reported cocaine users and non-
users at the turn of the century. The secondary
purpose was to compare the odds of acute coronary
syndrome outcomes between cocaine users and
non-users.
Design: Nested matched caseecontrol study using
data from the Internet Tracking Registry of Acute
Coronary Syndromes.
Setting: Extracted data of patients from eight US
institutions composed of six academic and two
community hospitals, with census varying between
10000 and 160000 visits per year.
Participants: 249 cases of self-reported cocaine users
and 249 matched controls. Matching was based on
age, race, sex and any history of known coronary
artery disease. Exclusion criteria were new ST
elevations on initial ECG and initial physician
impression of acute myocardial infarction.
Primary and secondary outcome
measures: Primary outcome was the conditional odds
of undergoing non-invasive and invasive testing for
coronary artery disease. Secondary outcome was the
occurrences of adverse cardiac outcomes within
30 days.
Results: Cocaine users underwent diagnostic testing
at similar rates compared with non-users (9.6% vs
8.0%, OR 1.24, CI 0.65 to 2.34). Adverse
cardiovascular outcomes occurred in four (1.6%)
cocaine users and in seven (2.8%) controls.
Conclusions: There was no increase in tendency for
testing associated with self-reported history of cocaine
use between 1999 and 2001. This suggests that even
10 years ago, cocaine use already had only a limited
role in the Emergency Department (ED) physician’s
decision-making process. Similar data analyses of
detailed registries can offer important contextual
information that can better direct resources for future
comparative effectiveness research.
INTRODUCTION
Cocaine is the most commonly reported
illicit drug abuse among patients presenting
to EDs; an estimated 5%e10% of the US
population has used cocaine, and it is asso-
ciated with more hospital visits and deaths
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ARTICLE SUMMARY
Article focus
- Was emergency physicians’ tendency for non-
invasive cardiac testing in chest pain patients
affected by patients’ self-reported history of
cocaine use prior to studies over the last
10 years which have shown no beneﬁts of non-
invasive testing in the cocaine-chest pain
population?
Key messages
- There was no association between patients’ self-
report of cocaine use and physicians’ testing
tendency.
- Even prior to recent studies supporting a minimal
testing strategy, emergency physicians were
already keeping testing to a minimum in patients
with cocaine chest pain, and earlier under-
standing of that practice pattern may have
reduced the amount of resources spent on
subsequent studies of non-invasive testing.
- Data analysis of detailed registries can be an
important tool in establishing practice patterns
from which further comparative effectiveness
research can be more selectively conducted.
Strengths and limitations of this study
- Data are obtained from a large multicenter
registry of patients with undifferentiated chest
pain, which means the results are fairly repre-
sentational of patients and physician practice
patterns across the USA.
- The database contained a low overall prevalence
of self-reported cocaine use, which means there
was inadequate power to detect any statistically
signiﬁcant differences in morbidity/mortality.
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Open Access Researchthan any other drug abuse.
1 Among patients presenting
to EDs with chest pain syndrome (CPS), 17% test posi-
tive for cocaine on urine drug screen.
2 Owing to the
drug’s powerful sympathomimetic properties, acute
cocaine intoxication has been associated with severe
hypertension, coronary vasospasm, myocardial infarction
and cardiac arrest.
3e6 Long-term cocaine abuse has been
shown to cause accelerated atherosclerosis, left ventric-
ular hypertrophy and dilated cardiomyopathy, thus
placing patients at higher risk of adverse cardiac
events.
37While cocaine’s adverse cardiac effects have
been well characterised, recent studies have revealed
that low-risk patients who presented to EDs with cocaine-
associated CPS can be safely discharged after a 23 h
observation period without further non-invasive
testing
89if serial ECGs and cardiac markers were
normal. In fact, over the last decade, multiple studies of
various non-invasive cardiac tests have only shown that
none of the tests are truly beneﬁcial in the low-risk
cocaine-related chest pain population.
10e13 These efforts
have given today’s ED physicians ﬁrm evidence for
a streamlined approach to cocaine-associated CPS.
However, whether self-reported cocaine use affected an
ED physician’s tendency to pursue cardiac testing prior
to these more recent ﬁndings had not been well
described and we questioned whether physicians were
actually subjecting cocaine-related CPS patients to
extensive cardiac testing. We used data from the Internet
Tracking Registry of Acute Coronary Syndrome
(I*trACS) to compare the odds of diagnostic testing for
CPS patients who reported recent cocaine use and who
did not between 1999 and 2001.
METHODS
I*trACS is a multicenter registry of over 17000 patients
who presented to one of the eight US or one non-US ED
between 1999 and 2001 with suspicion of acute coronary
syndrome (ACS). Prospective data, including presenting
signs and symptoms, ECG ﬁndings and the ED physi-
cian’s initial impression of risk, were systematically
collected. Medical record review or daily follow-up was
used to obtain cardiac biomarker results, invasive and
non-invasive testing, treatments, procedures and in-
hospital outcomes. Medical record review and telephone
follow-up were used to obtain 30-day outcomes. Further
details of the registry have been published previously.
14
For this analysis, we extracted data for patients
presenting to one of the eight institutions in the US;
non-US institutions may not have similar practice
patterns owing to differences in culture or care stan-
dards. The eight US institutions formed a representative
cross section of providers in the USA. There were six
academic and two community hospitals, with census
varying between 10000 and 160000 visits during the
study period. Providers of care to indigent and non-
indigent populations were both well represented, with
the proportion of patients receiving Medicaid or unin-
sured ranging from 17% to 67%. Patients with new
ST-segment elevation on the presenting ECG or with an
initial impression of acute myocardial infarction (AMI)
were not included since management of these patients
was likely independent of underlying cardiac risk factors.
At the time of the registry data collection, physicians
were asked to make a distinction between AMI and
unstable angina/non-Q-wave myocardial infarction
when making an initial impression before results of any
cardiac biomarkers were obtained. From among the
remaining patients, cases were selected based on a self-
reported history of cocaine use and each case was then
matched with a control based on 5-year age categories,
race, sex and any prior history of coronary artery disease
(CAD). One-to-one matching was used because self-
reported cocaine use was more common among younger
subjects in the registry, and there were insufﬁcient
controls for successful age matching if a higher ratio was
used. Matching on additional risk factors was also not
performed since the number of younger patients not
reporting cocaine use included in the registry was too
small.
The primary outcome was the occurrence of non-
invasive or invasive assessment of CAD. Non-invasive
testing was deﬁned as exercise treadmill or rest or stress
nuclear scintigraphy or echocardiography. Invasive
testing was deﬁned as percutaneous diagnostic coronary
angiography. The secondary outcome was a composite
outcome of conﬁrmed ACS, coronary revascularisation
or all-cause mortality within 30 days of the index ED visit.
Conﬁrmed ACS was deﬁned as reversible ischaemia on
provocative testing, CAD documented to be >70% on
coronary angiography or non-ST-segment elevation AMI
as determined by positive cardiac biomarkers (CK-MB,
TnI or TnT). As different sites participating in the
registry used different assays for measuring cardiac
biomarkers, results were recorded only as positive or
negative.
Data are described using means and SDs or frequen-
cies and percentages. Because the design involved
matching cases to controls, the observations (or
subjects) in the analysis were not independent. To
prevent the overestimation of the OR that occurs when
matching occurs in the design, conditional logistic
regression was used to determine whether a report of
cocaine use impacted the odds of undergoing non-
invasive or invasive testing. All analyses were conducted
using SPSS V.14.0 (SPSS Inc.).
RESULTS
Data for 17713 visits are available in the registry. There
were 14185 visits to sites in the USA. Of those visits, 647
(4.6%) were entirely lost to follow-up. US visits were
excluded for the following reasons: 217 had undocu-
mented age, race or sex, 587 had an initial impression of
AMI and 824 had new ST-segment elevations. Of the
remaining 12631, there were 249 visits (cases) in which
the patient self-reported cocaine use (2.0%). Cases were
successfully matched 1:1 with visits at which cocaine use
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race, sex and history of CAD except for a single case; one
male aged <25 years without a history of CAD was
matched with a male aged 26 years without a history of
CAD. Of the 249 cases of self-reported cocaine users, 20
(8.0%) were entirely lost to follow-up. Of the 249
matched controls, 20 (8.0%) were also lost to follow-up.
Characteristics of cases and controls are described in
table 1. The proportion of tobacco users was greater
among the cases than among controls (73.1% vs 43.4%),
and more cases prompted an initial physician impression
of high-risk chest pain (34.9% vs 20.1%). More controls
had an initial physician impression of a non-cardiac
aetiology than the cases (32.9% vs 16.5%). Statistical
testing of differences was not performed due to the
matched nature of the data.
Table 2 shows the rates of testing conducted among
cocaine users and controls and the conditional ORs and
95% CIs. The OR (95% CI) for non-invasive testing and
angiography are 1.55 (0.72 to 3.30) and 1.00 (0.42 to
2.40), respectively. Overall, the rates of non-invasive
testing and angiography were similar between the self-
reported cocaine users and the controls, with
a combined OR (95% CI) of 1.24 (0.65 to 2.34). Table 3
shows the incidence and ORs of various methods of non-
invasive myocardial perfusion evaluation. No patient had
a myocardial perfusion evaluation within 30 days
following hospital discharge. The primary outcomes of
combined angiography or non-invasive testing occurred
in only 9.6% and 8.0% of self-reported cocaine users and
controls, respectively. The numbers of non-invasive and
invasive procedures cannot be summed as an individual
patient could have had both types of testing performed.
Also, adverse events were rare in both cases and controls
(1.6% and 2.8%, respectively) with only one death
overall (a control) within 30 days.
DISCUSSION
We found that patients presenting to the ED with CPS
and a self-reported history of recent cocaine use, without
new ST-segment elevation on the presenting ECG or an
initial impression of AMI, received similar rates of
objective testing for CAD when compared with case-
matched control patients without a self-reported history
of cocaine use. Our study is the ﬁrst to speciﬁcally report
ED physicians’ testing tendency for underlying CAD in
low-risk patients with self-reported cocaine use during
a time period when outcome data were only just
emerging. Early work had suggested that patients
presenting with cocaine-related CPS are at high risk for
short-term adverse outcomes.
3 5 However, more recent
studies have revealed that the short-term rate of adverse
events for patients with cocaine-related CPS is actually
lower than those with non-cocaine-related CPS.
89The
entry criteria of self-reported cocaine usage is clinically
important as patient history is the primary means by
which emergency physicians determine what level of
evaluation is necessary in patients presenting with CPS.
Our ﬁnding of a lack of difference in testing tendency
may initially seem surprising owing to the amount of
literature in the 1990s suggesting that cocaine usage was
Table 1 Characteristics of cases and controls
Controls Cases
Demographics
Age in years 39.9 (9.1) 39.9 (9.1)
Female 70 (28.1) 70 (28.1)
Male 179 (71.9) 179 (71.9)
White 40 (16.1) 40 (16.1)
AfricaneAmerican 178 (71.5) 178 (71.5)
Other 31 (12.4) 31 (12.4)
History
Family history of
heart disease
77 (30.9) 81 (32.5)
Current smoker 108 (43.4) 182 (73.1)
Diabetes 33 (13.3) 26 (10.4)
Hypertension 83 (33.3) 79 (31.7)
Hyperlipidaemia 20 (8.0) 15 (6.0)
Angina 16 (6.4) 18 (7.2)
Coronary artery disease 23 (9.2) 23 (9.2)
Congestive heart failure 13 (5.2) 10 (4.0)
Initial impression
Unstable angina/
non-Q-wave MI
13 (5.2) 6 (2.4)
High-risk chest pain 50 (20.1) 87 (34.9)
Low-risk chest pain 104 (41.8) 115 (46.2)
Non-cardiac chest pain 82 (32.9) 41 (16.5)
Data are given as means and SDs or frequencies and percentages.
Table 2 Outcomes experienced among cases and controls
Controls Cases Conditional OR (95% CI) p Value
Non-invasive testing 13 (5.2) 19 (7.6) 1.55 (0.72 to 3.30) 0.261
Angiography 10 (4.0) 10 (4.0) 1.00 (0.42 to 2.40) 1.000
Primary outcome 20 (8.0) 24 (9.6) 1.24 (0.65 to 2.34) 0.517
Recurrent MI 5 (2.0) 2 (0.8) Not donedtoo few outcomes
Percutaneous coronary intervention 1 (0.4) 1 (0.4)
Coronary artery bypass graft 1 (0.4) 0 (0.0)
Death 0 (0.0) 1 (0.4)
Revascularation, recurrent MI or death 7 (2.8) 4 (1.6)
The conditional odds of outcomes are shown.
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outcomes.
6 15 16 However, while cocaine was reported to
induce coronary vasospasm
41 71 8and cocaine users were
being reported as having a higher risk of AMI immedi-
ately after their last use,
6 Amin and Hollander had
reported that the majority of at-risk patients
were presenting with initial ECG changes suggestive of
ACS.
15 19 20 Our study group was fairly young, and the
majority did not have multiple traditional cardiac risk
factors in their histories (table 1) or any ischaemic ECG
changes. More recent work by Hermann et al
21 has
shown that in young low-risk chest pain patients without
a history of cocaine use, positive non-invasive cardiac
tests are primarily false positives and that there is no role
for non-invasive testing in such a population. Our
primary outcome shows that even a decade ago, ED
physicians had already in practice extended Hermann’s
ﬁndings to their approach to cocaine users as well that in
a low-risk population, even with the possibility of addi-
tional risk conferred by cocaine use, non-invasive cardiac
testing was unnecessary and suspicion of underlying
CAD was low.
While self-reported cocaine users received an evalua-
tion similar to putatively lower risk patients without
cocaine use, our secondary outcome suggests that the
ED physicians’ clinical decision-making process was
appropriate. Despite the lack of aggressive testing, the
occurrence of 30-day ACS outcomes was low (2%e3%,
table 2) and is consistent with rates reported in more
recent studies of low-risk chest pain patients where
cocaine users were speciﬁcally excluded.
22 23
Over the last 10 years, several groups have looked at
various non-invasive methods of detecting CAD in
cocaine users including dobutamine stress testing,
myocardial perfusion imaging or more recently CT
angiography.
10e13 None of the studies has convincingly
demonstrated a beneﬁt to more testing in self-reported
cocaine users. In fact, results of cardiac testing in low-risk
cocaine users have been similar to those found in non-
cocaine users: mandatory exercise stress testing results in
a low rate of positive ﬁndings
9; myocardial perfusion
testing does not detect any reversible ischaemia in
patients without ECG changes
11 and there is limited
angiographic evidence of coronary disease in patients
without an abnormal ECG or elevated troponins.
24
Diercks et al
25 found a rate of positive non-invasive test
results of 17% and 14% for stimulant and cocaine users
admitted to a chest pain observation unit, respectively.
However, whether other factors inﬂuenced either the
decision for testing or the high rate of positive results
was unclear, and the high positive rate may suggest this
was a high-risk population at baseline.
Our data from this registry show that as far back as
10 years ago, in an otherwise low-risk population without
ischaemic ECG changes, self-reported cocaine use alone
did not increase ED physicians’ tendency for further
cardiac testing. This practice pattern has been more
recently validated by studies by Weber and Cunningham.
Weber found that the 30-day events rates were similar in
patients with cocaine-associated chest pain whether they
received an inpatient evaluation for CAD or not. Weber’s
reported 1.6% rate of non-fatal MIs at 30 days is similar
to our combined adverse events rate of 1.6%.
9
Cunningham et al
8 found that in 219 cocaine users with
loweintermediate risk of CAD presenting to an ED with
CPS, discharge after an uneventful stay in a 23 h obser-
vation unit resulted in no missed MIs at 1-year follow-up.
Our study has several limitations. Foremost is that we
were not able to differentiate between those patients
who presented immediately after cocaine use and those
who merely reported a prior history of cocaine use. As
the highest risk period is shortly after cocaine use,
a sample of patients who presented later may have
resulted in a lower complication rate than expected.
Second, the 2% prevalence of cocaine use by self-report
is much lower than the 17% prevalence of cocaine use
conﬁrmed by laboratory results cited by other studies.
The potential lack of detection of cocaine in some
percentage of the non-cocaine group may have made the
two groups more similar than different. However, the
rates of non-invasive testing and adverse events in both
groups were already so low that any more rigorous
distinction of users from non-users would probably not
have been able to reduce the control group’s rates to any
statistically or clinically signiﬁcant degree. Third, while
matching was based on demographics and any known
CAD, we did not match for the presences of other
cardiac risk factors. Since physicians use cardiac risk
factors to help determine the extent of cardiac testing,
a more rigorous case matching may have eliminated
several possible confounders. However, too-rigorous
matching could also result in overestimation of effects,
and despite the large sample size of the registry, we
found that we were already not able to completely match
the two groups. The only two notable differences
between our cases and controls, more tobacco use and
more initial impressions of high-risk chest pain in the
cocaine users, would have been expected to bias our
results towards a greater difference in testing tendency
between the two groups. The lack of a difference in
testing tendency despite the differences suggests that
further matching may not be necessary and that the
cases and controls were somewhat homogeneous.
Fourth, it is possible that practice patterns were hospital
Table 3 Rate of each type of non-invasive testing
performed during hospital stay for controls and cases
Controls Cases
N (%) N (%)
Exercise treadmill 6 (2.4) 4 (1.6)
Stress nuclear medicine or
echocardiogram study
3 (1.2) 9 (3.6)
Rest nuclear medicine or
echocardiogram study
5 (2.0) 9 (3.6)
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adjusted the model for the primary outcome for site.
The conditional OR for the primary outcome in that
analysis was 0.80 (95% CI 0.39 to 1.66), p¼0.556, which
does not change our conclusion. We note that the
magnitude of the difference between cases and controls
was only 1.6%, and in our data, the proportion of
discordant pairs was 0.15. The observed power was
therefore about 9%. With a sample size of 249 pairs, the
difference in proportions would need to be 6.8% or
greater to have achieved statistical signiﬁcance. Lastly, by
speciﬁcally excluding patients with STelevations on ECG
or those with initial impressions of AMI from our study,
we selected lower risk cocaine users without obvious
acute pathophysiology. This was consistent with our
intention to determine the impact of a self-reported
history of cocaine use on emergency physicians’
management strategy. While exclusion of those with
obvious acute presentations may have underestimated
the incidence of diagnostic testing in all cocaine users,
the presence of concerning ECG changes or elevated
biomarkers would have led to further cardiac testing in
any patient regardless of history.
Our study is a descriptive evaluation of ED physicians’
practice patterns in managing self-reported cocaine
users presenting with a single episode of acute chest pain
10 years ago. Our patients were relatively young and had
few risk factors for adverse cardiac events. Our analysis
was not powered to detect a difference in the rate of
adverse cardiac events. Our low rates at 30-day follow-up
should not be interpreted as an accurate reﬂection of
life-long cardiac disease burden in cocaine users and
certainly does not reﬂect long-term consequences of
cocaine use. Especially since others have found that even
in cocaine addicts with a mean age of 32 years, 36% had
>75% atherosclerotic stenosis in at least one epicardial
coronary artery.
3 Also, the 1.6% recurrent MIs in
Weber’s study were found exclusively in those who
continued to use cocaine.
9 Chronic or older cocaine
users probably require closer routine monitoring and
may beneﬁt from outpatient non-invasive testing, long-
term follow-up and drug dependence interventions. In
fact, while a history of cocaine use may not have
a signiﬁcant role in an ED physician’s decision-making
process regarding diagnostic testing, it should be noted
that current ACS treatment recommendations do vary
based upon recent use of cocaine,
26 and therefore, it is
still important to solicit this information in the ED.
Future studies may be needed to further deﬁne the
morbidity or mortality beneﬁts of earlier initiation of
outpatient cardiac testing in cocaine users.
Our ﬁndings are consistent with currently published
guidelines on the management of cocaine chest pain
and should not alter them. However, our ﬁndings do
highlight the utility of registry data. During the last
decade, multiple studies have been conducted on
extensive testing strategies, despite the fact that a mini-
malist practice pattern was already in place and was
yielding a very low rate of adverse outcomes. In fact, no
study on non-invasive cardiac testing protocols in
a similar population has demonstrated any improvement
in overall mortality beyond what has been shown with
a 23 h observation period. The I*trACS registry was
compiled in an era when electronic medical records
(EMRs) were still under development, and data entry
was done by hand. While raw data were collected
between 1999 and 2001, the registry was not completed
and published until 2006. The availability of compu-
terised means of data collection and extraction would
mean earlier availability of descriptive and outcome
reports. If, over a decade ago, we had EMRs efﬁciently
providing quality data to help us describe and evaluate
the treatment patterns for cocaine-related chest pain
patients, we may have potentially spared all the more
recent resources that were used to disprove the utility of
non-invasive cardiac testing. As EMRs become more
advanced and ubiquitous, we have the opportunity to
build detailed registries across the entire spectrum of
disease processes encountered in the ED. The increased
focus on comparative effectiveness research means that
descriptive outcomes studies will only become more vital
in establishing the contextual background against which
different therapies may be compared. Without an
understanding of established practice patterns and
outcomes, we cannot know what, much less how, to
improve upon them.
CONCLUSIONS
We found that between 1999 and 2001, in patients
presenting to the ED with CPS but without ECG changes
or an initial impression of AMI, there was no association
between physician practice patterns and a self-reported
history of cocaine use. Furthermore, the risk of ACS
events within 30 days of presentation was low. Our find-
ings show that almost 10 years prior to recent prospec-
tive studies validating the safety of a 23 h observation
protocol and disproving the utility of extensive non-
invasive cardiac testing, ED physicians were already
electing for a minimally involved investigation. Further-
more, the low rate of adverse events associated with their
practice pattern has yet to be signiﬁcantly reduced by
any more recent published studies involving more
extensive cardiac testing protocols. Our study illustrates
the importance of registries in patient-centred outcomes
research. In the era of EMRs, the ability to efﬁciently
build registries and generate outcomes data will be
essential as focus shifts towards comparative effectiveness
research and more efﬁcient utilisation of resources.
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